CLINICAL_TRIALS
trial_result
· 2019-05-10
Clinical Trial Update: Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus
Summary
A completed clinical trial evaluating long-term daily use of Trazenta tablets in patients with type 2 diabetes; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2019-05-10